These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26487928)

  • 1. Botulinum Neurotoxin Type A in Neurology: Update.
    Orsini M; Leite MA; Chung TM; Bocca W; de Souza JA; de Souza OG; Moreira RP; Bastos VH; Teixeira S; Oliveira AB; Moraes Bda S; Matta AP; Jacinto LJ
    Neurol Int; 2015 Sep; 7(2):5886. PubMed ID: 26487928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin: basic science and clinical uses in otolaryngology.
    Blitzer A; Sulica L
    Laryngoscope; 2001 Feb; 111(2):218-26. PubMed ID: 11210864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the neurologic applications of botulinum toxins.
    Evidente VG; Adler CH
    Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxins in neurological disease.
    Comella CL; Pullman SL
    Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding use of botulinum toxin.
    Bhidayasiri R; Truong DD
    J Neurol Sci; 2005 Aug; 235(1-2):1-9. PubMed ID: 15990116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Applications of botulinum toxin in Neurology].
    Garcia-Ruiz PJ
    Med Clin (Barc); 2013 Jul; 141(1):33-6. PubMed ID: 23434466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.
    Dodick DW
    Headache; 2003; 43 Suppl 1():S25-33. PubMed ID: 12887391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
    Sycha T; Kranz G; Auff E; Schnider P
    J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current clinical applications of botulinum toxin.
    Truong DD; Stenner A; Reichel G
    Curr Pharm Des; 2009; 15(31):3671-80. PubMed ID: 19925419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mode of action and effects of botulinum neurotoxin A].
    Périé S; Lacau St-Guily J
    Ann Otolaryngol Chir Cervicofac; 1996; 113(2):73-8. PubMed ID: 8999747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of botulinum neurotoxin serotype A.
    Wenzel RG
    Am J Health Syst Pharm; 2004 Nov; 61(22 Suppl 6):S5-10. PubMed ID: 15598004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxins: pharmacology and its current therapeutic evidence for use.
    Panicker JN; Muthane UB
    Neurol India; 2003 Dec; 51(4):455-60. PubMed ID: 14742921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for antinociceptive activity of botulinum toxin type A in pain management.
    Aoki KR
    Headache; 2003; 43 Suppl 1():S9-15. PubMed ID: 12887389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life.
    Moawad EM; Abdallah EA
    Glob Pediatr Health; 2015; 2():2333794X15590149. PubMed ID: 27335961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transynaptic Action of Botulinum Neurotoxin Type A at Central Cholinergic Boutons.
    Caleo M; Spinelli M; Colosimo F; Matak I; Rossetto O; Lackovic Z; Restani L
    J Neurosci; 2018 Nov; 38(48):10329-10337. PubMed ID: 30315128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin type A and cholinergic system].
    Bach-Rojecky L; Relja M; Filipović B; Lacković Z
    Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type B: an overview of its biochemistry and preclinical pharmacology.
    Callaway JE; Arezzo JC; Grethlein AJ
    Semin Cutan Med Surg; 2001 Jun; 20(2):127-36. PubMed ID: 11474745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Botulinum neurotoxin].
    Poulain B
    Rev Neurol (Paris); 2010 Jan; 166(1):7-20. PubMed ID: 19846187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.